Smith & Nephew plc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Smith & Nephew plc trades at $29.76 (market cap $12.54B), while Direxion Daily Semiconductor Bear 3X Shares trades at $39.87. The key difference: Smith & Nephew plc pays a 2.65% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals.
| SNN | SOXS | |
|---|---|---|
Market Cap | $12.54B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $38.70 | $1.49K |
52-Week Low | $28.73 | $32.50 |
Enterprise Value | $15.57B | — |
Dividend Yield | 2.65% | — |
Signals from Pluang's Aura AI — not financial advice
Smith & Nephew (SNN) trades at $29.76, down 1.06% with bearish technical signals. The company shows improving fundamentals with revenue growth from $5.8B to $6.2B and net income margin expanding to 10.08% in 2025. Recent Q2 2026 earnings beat expectations but the company lowered full-year revenue guidance from 6% to 4% growth due to U.S. Orthopaedics weakness.
While valuation multiples appear reasonable (P/E 20.41, EV/EBITDA 9.9), the stock faces headwinds from mixed earnings performance and cautious analyst sentiment. The primary investment case hinges on execution in robotics and wound care segments offsetting orthopedic challenges, with downside risk from continued U.S. market softness.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, is trading at $39.97, down 11.59% in the past 24 hours amid a bearish technical signal. The ETF benefits from recent semiconductor sector weakness, with news highlighting its surge during chip stock sell-offs. A 1:10 stock split is scheduled for July 26, 2026, while technical indicators show oversold conditions with RSI at 26.30.
The outlook remains volatile, with SOXS positioned to gain from continued semiconductor sector pressure, though leveraged inverse exposure carries high risk. Key risks include rapid AI-driven chip rallies reversing bearish bets. Investors should weigh sector volatility against the ETF's structure, with support at $41 and resistance at $45.
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →